dexmedetomidine has been researched along with Systemic Inflammatory Response Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dong, S; Liao, L; Liu, J; Liu, Y; Zeng, L; Zhang, T | 1 |
| Du, Z; Qu, SQ; Wei, SW; Xiang, Z; Zhang, XY | 1 |
| Akeju, O; Bilotta, F; Brown, EN; Cudemus, G; D'Alessandro, DA; Deng, H; DiBiasio, A; Gitlin, JA; Hahm, EY; Hobbs, LE; Houle, TT; Ibala, R; Loggia, ML; Pavone, KJ; Qu, J; Shaefi, S; Shelton, KT; Tolis, G; Westover, MB | 1 |
| Deng, Y; Gan, X; Ge, M; Gong, C; Hei, Z; Li, X; Tan, F; Zhou, S; Zhu, Q | 1 |
| Habe, K; Hamada, K; Kawasaki, C; Kawasaki, T; Sata, T; Ueki, M | 1 |
| Bulow, NM; Colpo, E; Correa, EF; Duarte, MF; Pereira, RP; Rocha, JB; Waczuk, EP | 1 |
6 trial(s) available for dexmedetomidine and Systemic Inflammatory Response Syndrome
| Article | Year |
|---|---|
Study on the protective mechanism of dexmedetomidine on the liver of perioperative diabetic patients: A randomized controlled trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Biomarkers; Blood Glucose; Cholesterol; Dexmedetomidine; Diabetes Mellitus, Type 2; Humans; Interleukin-6; Liver; Ropivacaine; Saline Solution; Superoxide Dismutase; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2022 |
The effect of dexmedetomidine premedication on postoperative systemic inflammatory response in children undergoing hernia repair surgery: A randomized controlled trial.
Topics: Child; Dexmedetomidine; Double-Blind Method; Herniorrhaphy; Humans; Hypnotics and Sedatives; Premedication; Prospective Studies; Systemic Inflammatory Response Syndrome | 2021 |
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, Cardiac Procedures; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Delirium; Dexmedetomidine; Double-Blind Method; Humans; Intensive Care Units; Sleep; Sleep Wake Disorders; Systemic Inflammatory Response Syndrome | 2018 |
Perioperative application of dexmedetomidine for postoperative systemic inflammatory response syndrome in patients undergoing percutaneous nephrolithotomy lithotripsy: results of a randomised controlled trial.
Topics: Administration, Intravenous; Adrenergic alpha-2 Receptor Agonists; Adult; Dexmedetomidine; Double-Blind Method; Female; Humans; Interleukin-6; Length of Stay; Male; Middle Aged; Nephrolithotomy, Percutaneous; Perioperative Care; Postoperative Complications; Postoperative Period; Systemic Inflammatory Response Syndrome; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |
The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass.
Topics: Aged; Analgesics, Non-Narcotic; Biomarkers; Cardiopulmonary Bypass; Dexmedetomidine; Female; Humans; Inflammation Mediators; Interleukin-6; Male; NF-kappa B; Postoperative Care; Prospective Studies; Sodium Chloride; Systemic Inflammatory Response Syndrome; Time Factors; Treatment Outcome | 2014 |
Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Analysis of Variance; Anesthesia, Intravenous; Blood Glucose; C-Reactive Protein; Coronary Artery Bypass; Creatine Kinase; Cytokines; Dexmedetomidine; Female; Humans; Hydrocortisone; Male; Middle Aged; Prospective Studies; Reference Values; Systemic Inflammatory Response Syndrome; Thiobarbituric Acid Reactive Substances; Time Factors; Troponin I | 2016 |